chr2-47414389-G-A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. BS2BS3_SupportingPP3_ModerateBP5BS4_Supporting
This summary comes from the ClinGen Evidence Repository: The MSH2 c.913G>A variant is predicted as a missense variant, p.(Ala305Thr). Its MAPP+PolyPhen-2 prior probability for pathogenicity is >0.81 (http://priors.hci.utah.edu/PRIORS). It showed lack of co-segregation with disease with Bayes Likelihood Ratio >0.05 & ≤0.482 (Insight database). It was identified in 2 individuals with CRC showing MSS or inconsistent MMR protein expression pattern. It has been functionally analyzed in several studies: functional Odds for Pathogenicity is >0.05 & ≤0.482 (Drost et al., 2011 PMID 22102614); proficient function, expression and localization (PMID 18822302); proficient function (PMID 33357406). It has been identified in co-occurrence in trans with a MSH2 known pathogenic variant (Invitae internal data). Therefore, this variant is classified as likely benign. LINK:https://erepo.genome.network/evrepo/ui/classification/CA022539/MONDO:0005835/137
Frequency
Consequence
NM_000251.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
- Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MSH2 | TSL:1 MANE Select | c.913G>A | p.Ala305Thr | missense | Exon 5 of 16 | ENSP00000233146.2 | P43246-1 | ||
| MSH2 | TSL:1 | c.913G>A | p.Ala305Thr | missense | Exon 5 of 16 | ENSP00000384199.1 | E9PHA6 | ||
| MSH2 | c.964G>A | p.Ala322Thr | missense | Exon 6 of 17 | ENSP00000588166.1 |
Frequencies
GnomAD3 genomes AF: 0.0000768 AC: 9AN: 117216Hom.: 0 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.0000603 AC: 15AN: 248830 AF XY: 0.0000595 show subpopulations
GnomAD4 exome AF: 0.000156 AC: 205AN: 1315136Hom.: 0 Cov.: 37 AF XY: 0.000142 AC XY: 93AN XY: 655584 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000768 AC: 9AN: 117216Hom.: 0 Cov.: 27 AF XY: 0.0000749 AC XY: 4AN XY: 53416 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at